Understanding voriconazole metabolism: a middle-out physiologically-based pharmacokinetic modelling framework integrating in vitro and clinical insights

Voriconazole (VRC), a broad-spectrum antifungal drug, exhibits nonlinear pharmacokinetics (PK) due to saturable metabolic processes, autoinhibition and metabolite-mediated inhibition on their own formation. VRC PK is also characterised by high inter- and intraindividual variability, primarily associ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Saleh, Ayatallah (VerfasserIn) , Schulz, Josefine (VerfasserIn) , Schlender, Jan-Frederik (VerfasserIn) , Aulin, Linda B. S. (VerfasserIn) , Konrad, Amrei-Pauline (VerfasserIn) , Kluwe, Franziska (VerfasserIn) , Mikus, Gerd (VerfasserIn) , Huisinga, Wilhelm (VerfasserIn) , Kloft, Charlotte (VerfasserIn) , Michelet, Robin (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 30 October 2024
In: Clinical pharmacokinetics
Year: 2024, Jahrgang: 63, Heft: 11, Pages: 1609-1630
ISSN:1179-1926
DOI:10.1007/s40262-024-01434-8
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s40262-024-01434-8
Volltext
Verfasserangaben:Ayatallah Saleh, Josefine Schulz, Jan-Frederik Schlender, Linda B.S. Aulin, Amrei-Pauline Konrad, Franziska Kluwe, Gerd Mikus, Wilhelm Huisinga, Charlotte Kloft, Robin Michelet

MARC

LEADER 00000caa a2200000 c 4500
001 1921987375
003 DE-627
005 20250717005356.0
007 cr uuu---uuuuu
008 250409s2024 xx |||||o 00| ||eng c
024 7 |a 10.1007/s40262-024-01434-8  |2 doi 
035 |a (DE-627)1921987375 
035 |a (DE-599)KXP1921987375 
035 |a (OCoLC)1528044235 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Saleh, Ayatallah  |e VerfasserIn  |0 (DE-588)1362741132  |0 (DE-627)1921988924  |4 aut 
245 1 0 |a Understanding voriconazole metabolism  |b a middle-out physiologically-based pharmacokinetic modelling framework integrating in vitro and clinical insights  |c Ayatallah Saleh, Josefine Schulz, Jan-Frederik Schlender, Linda B.S. Aulin, Amrei-Pauline Konrad, Franziska Kluwe, Gerd Mikus, Wilhelm Huisinga, Charlotte Kloft, Robin Michelet 
264 1 |c 30 October 2024 
300 |b Illustrationen 
300 |a 22 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 09.04.2025 
520 |a Voriconazole (VRC), a broad-spectrum antifungal drug, exhibits nonlinear pharmacokinetics (PK) due to saturable metabolic processes, autoinhibition and metabolite-mediated inhibition on their own formation. VRC PK is also characterised by high inter- and intraindividual variability, primarily associated with cytochrome P450 (CYP) 2C19 genetic polymorphism. Additionally, recent in vitro findings indicate that VRC main metabolites, voriconazole N-oxide (NO) and hydroxyvoriconazole (OHVRC), inhibit CYP enzymes responsible for VRC metabolism, adding to its PK variability. This variability poses a significant risk of therapeutic failure or adverse events, which are major challenges in VRC therapy. Understanding the underlying processes and sources of these variabilities is essential for safe and effective therapy. This work aimed to develop a whole-body physiologically-based pharmacokinetic (PBPK) modelling framework that elucidates the complex metabolism of VRC and the impact of its metabolites, NO and OHVRC, on the PK of the parent, leveraging both in vitro and in vivo clinical data in a middle-out approach. 
700 1 |8 1\p  |a Schulz, Josefine  |d 1991-  |e VerfasserIn  |0 (DE-588)1257542826  |0 (DE-627)1801818835  |4 aut 
700 1 |a Schlender, Jan-Frederik  |e VerfasserIn  |4 aut 
700 1 |a Aulin, Linda B. S.  |e VerfasserIn  |4 aut 
700 1 |a Konrad, Amrei-Pauline  |e VerfasserIn  |4 aut 
700 1 |8 2\p  |a Kluwe, Franziska  |e VerfasserIn  |0 (DE-588)134077206X  |0 (DE-627)1900894564  |4 aut 
700 1 |a Mikus, Gerd  |e VerfasserIn  |0 (DE-588)110903137  |0 (DE-627)691097941  |0 (DE-576)336988710  |4 aut 
700 1 |8 3\p  |a Huisinga, Wilhelm  |e VerfasserIn  |0 (DE-588)116305867X  |0 (DE-627)1027295649  |0 (DE-576)507770366  |4 aut 
700 1 |a Kloft, Charlotte  |e VerfasserIn  |4 aut 
700 1 |a Michelet, Robin  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Clinical pharmacokinetics  |d Berlin [u.a.] : Springer, 1976  |g 63(2024), 11, Seite 1609-1630  |h Online-Ressource  |w (DE-627)327644974  |w (DE-600)2043781-X  |w (DE-576)10337339X  |x 1179-1926  |7 nnas  |a Understanding voriconazole metabolism a middle-out physiologically-based pharmacokinetic modelling framework integrating in vitro and clinical insights 
773 1 8 |g volume:63  |g year:2024  |g number:11  |g pages:1609-1630  |g extent:22  |a Understanding voriconazole metabolism a middle-out physiologically-based pharmacokinetic modelling framework integrating in vitro and clinical insights 
856 4 0 |u https://doi.org/10.1007/s40262-024-01434-8  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
883 |8 1\p  |a cgwrk  |d 20250505  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
883 |8 2\p  |a cgwrk  |d 20250505  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
883 |8 3\p  |a cgwrk  |d 20250505  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
951 |a AR 
992 |a 20250409 
993 |a Article 
994 |a 2024 
998 |g 110903137  |a Mikus, Gerd  |m 110903137:Mikus, Gerd  |d 50000  |e 50000PM110903137  |k 0/50000/  |p 7 
999 |a KXP-PPN1921987375  |e 4698761956 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"Understanding voriconazole metabolism","title":"Understanding voriconazole metabolism","subtitle":"a middle-out physiologically-based pharmacokinetic modelling framework integrating in vitro and clinical insights"}],"person":[{"given":"Ayatallah","family":"Saleh","role":"aut","roleDisplay":"VerfasserIn","display":"Saleh, Ayatallah"},{"roleDisplay":"VerfasserIn","display":"Schulz, Josefine","role":"aut","family":"Schulz","given":"Josefine"},{"roleDisplay":"VerfasserIn","display":"Schlender, Jan-Frederik","role":"aut","family":"Schlender","given":"Jan-Frederik"},{"family":"Aulin","given":"Linda B. S.","display":"Aulin, Linda B. S.","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Konrad","given":"Amrei-Pauline","display":"Konrad, Amrei-Pauline","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Kluwe, Franziska","given":"Franziska","family":"Kluwe"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Mikus, Gerd","given":"Gerd","family":"Mikus"},{"family":"Huisinga","given":"Wilhelm","display":"Huisinga, Wilhelm","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Kloft, Charlotte","given":"Charlotte","family":"Kloft"},{"role":"aut","display":"Michelet, Robin","roleDisplay":"VerfasserIn","given":"Robin","family":"Michelet"}],"recId":"1921987375","language":["eng"],"note":["Gesehen am 09.04.2025"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.1007/s40262-024-01434-8"],"eki":["1921987375"]},"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"30 October 2024"}],"name":{"displayForm":["Ayatallah Saleh, Josefine Schulz, Jan-Frederik Schlender, Linda B.S. Aulin, Amrei-Pauline Konrad, Franziska Kluwe, Gerd Mikus, Wilhelm Huisinga, Charlotte Kloft, Robin Michelet"]},"relHost":[{"title":[{"title_sort":"Clinical pharmacokinetics","title":"Clinical pharmacokinetics"}],"recId":"327644974","language":["eng"],"disp":"Understanding voriconazole metabolism a middle-out physiologically-based pharmacokinetic modelling framework integrating in vitro and clinical insightsClinical pharmacokinetics","note":["Gesehen am 06.03.13","Ungezählte Beil.: Suppl"],"type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"pages":"1609-1630","issue":"11","year":"2024","extent":"22","text":"63(2024), 11, Seite 1609-1630","volume":"63"},"pubHistory":["1.1976 -"],"id":{"issn":["1179-1926"],"eki":["327644974"],"zdb":["2043781-X"]},"origin":[{"publisherPlace":"Berlin [u.a.] ; Auckland","publisher":"Springer ; Adis Intern.","dateIssuedKey":"1976","dateIssuedDisp":"1976-"}],"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"noteIll":"Illustrationen","extent":"22 S."}]} 
SRT |a SALEHAYATAUNDERSTAND3020